Tether, issuer of the USDT stablecoin, expects to report a net profit of $15 billion at the end of 2025. This projection comes amid a favorable crypto regulatory environment in the United States, driving interest in stablecoins and other digital assets. Related Reading: Tether Mints Another 1B USDT – $7B in Stablecoins Issued Since The […]Tether, issuer of the USDT stablecoin, expects to report a net profit of $15 billion at the end of 2025. This projection comes amid a favorable crypto regulatory environment in the United States, driving interest in stablecoins and other digital assets. Related Reading: Tether Mints Another 1B USDT – $7B in Stablecoins Issued Since The […]

Tether Projected To Hit $15 Billion Profit In 2025 – Report

2025/10/26 07:30
2 min read

Tether, issuer of the USDT stablecoin, expects to report a net profit of $15 billion at the end of 2025. This projection comes amid a favorable crypto regulatory environment in the United States, driving interest in stablecoins and other digital assets.

Tether In Funding Talks With Prospective TradFi Investors

In a recent post on Friday, Bloomberg shared key developments on Tether Holdings Ltd, operator of the largest stablecoin in the market. Notably, the company’s CEO and popular crypto figure Paolo Ardoino outlined positive profit predictions of $15 billion by 2025’s end, while speaking in an interview at the recent Plan B Forum in Lugano, Switzerland. 

Bloomberg’s report indicates this projection can be linked to a rapid stablecoin adoption combined with surging investors’ interest in an equity stake in the market’s biggest player. In July, US President Donald Trump signed the GENIUS Act into law, thereby creating a comprehensive regulatory framework for stablecoin operations. 

The legislation addresses several aspects, such as licensing, reserve requirements, consumer and investor protection, and market structure, thereby helping demystify and provide the needed guardrails for a nascent financial industry.

According to Bloomberg, Tether entered discussions with prospective investors last month to raise $20 billion in exchange for a 3% stake in its company. Among these companies reportedly include Japanese firm SoftBank Group Corp. and London-based Ark Investment Management. 

Paolo Ardoino spoke about these potential investments, explaining Tether’s approach and openness to such partnerships. 

Ardoino said:

He further added: 

Tether’s USDT currently boasts a market cap value of $182.92 billion, showcasing a 57.5% dominance in the stablecoin market. The company is reportedly set to launch a new USAT token in December, designed to be a US-focused product in compliance with federal regulations, as indicated by the GENIUS Act.

Tether-Backed Rumble Introduces Bitcoin Tip Creators

In other news, video-sharing platform Rumble is now set to introduce Bitcoin tipping for its creators, according to its CEO Chris Paglovski, while speaking onstage also at the Plan B Forum in Switzerland.

Notably, the company is teaming up with Tether on this feature, with projections of a full rollout in the next five to seven weeks. This development follows the stablecoin issuer’s notable investment of $775 million into Rumble in December 2024.

Tether
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03